Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
NCT02400359Phase 4Active, not recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2014
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorcaserin in obesity, sponsored by Beth Israel Deaconess Medical Center. Started Oct 2014; status: active, not recruiting.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02400359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400359.